Taro Pharmaceutical Industries Revenue 2006-2019 | TARO

Taro Pharmaceutical Industries revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Taro Pharmaceutical Industries Annual Revenue
(Millions of US $)
2019 $670
2018 $662
2017 $879
2016 $951
2015 $863
2014 $759
2013 $671
2012 $145
2011 $
2011 $108
2010 $
2010 $89
2009 $85
2008 $313
2007 $184
2006 $
2006 $298
2005 $79
Taro Pharmaceutical Industries Quarterly Revenue
(Millions of US $)
Q2 2019 $161
Q1 2019 $161
Q4 2019 $180
Q3 2018 $176
Q2 2018 $159
Q1 2018 $155
Q4 2018 $175
Q3 2017 $155
Q2 2017 $170
Q1 2017 $161
Q4 2017 $196
Q3 2016 $220
Q2 2016 $229
Q1 2016 $234
Q4 2016 $265
Q3 2015 $258
Q2 2015 $212
Q1 2015 $215
Q4 2015 $244
Q3 2014 $238
Q2 2014 $251
Q1 2014 $130
Q4 2014 $187
Q3 2013 $214
Q2 2013 $205
Q1 2013 $153
Q4 2013 $165
Q3 2012 $186
Q2 2012 $161
Q1 2012 $159
Q4 2012 $145
Q3 2011 $148
Q2 2011 $138
Q1 2011 $112
Q4 2011 $108
Q3 2010 $102
Q2 2010 $103
Q1 2010 $98
Q4 2010 $89
Q3 2009 $85
Q2 2009 $94
Q1 2009 $97
Q4 2009
Q3 2008 $85
Q2 2008 $90
Q3 2007
Q3 2006
Q4 2006 $79
Q3 2005 $68
Q2 2005 $73
Q1 2005 $79
Q4 2005 $79
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.635B $0.670B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.527B 10.04
Zoetis (ZTS) United States $57.408B 34.34
Astellas Pharma (ALPMY) Japan $32.261B 16.11
Eisai (ESALY) Japan $20.266B 39.08
UCB SA (UCBJF) Belgium $15.697B 0.00
Grifols, S.A (GRFS) Spain $15.422B 20.21
Merck (MKGAF) Germany $14.921B 20.36
Neurocrine Biosciences (NBIX) United States $10.834B 511.48
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.341B 0.00
Ionis Pharmaceuticals (IONS) United States $9.028B 18.28
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.285B 10.58
Sage Therapeutics (SAGE) United States $7.761B 0.00
Catalent (CTLT) United States $7.514B 30.57
Arrowhead Pharmaceuticals (ARWR) United States $6.571B 99.51
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.986B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.881B 17.55
United Therapeutics (UTHR) United States $3.915B 0.00
FibroGen (FGEN) United States $3.860B 113.44
Nektar Therapeutics (NKTR) United States $3.423B 0.00
Evotec AG (EVTCY) Germany $3.226B 52.78
PTC Therapeutics (PTCT) United States $3.079B 0.00
Heron Therapeutics (HRTX) United States $2.396B 0.00
Xencor (XNCR) United States $2.245B 68.24
Portola Pharmaceuticals (PTLA) United States $2.163B 0.00
Zogenix (ZGNX) United States $2.046B 0.00
Tilray (TLRY) Canada $1.965B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.921B 56.84
Ironwood Pharmaceuticals (IRWD) United States $1.892B 60.33
ChemoCentryx (CCXI) United States $1.704B 0.00
USANA Health Sciences (USNA) United States $1.582B 16.89
Corcept Therapeutics (CORT) United States $1.554B 18.89
Enanta Pharmaceuticals (ENTA) United States $1.252B 28.58
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.233B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.208B 8.24
Endo (ENDP) Ireland $1.132B 2.08
ArQule (ARQL) United States $1.100B 0.00
Karyopharm Therapeutics (KPTI) United States $1.046B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.033B 0.00
Radius Health (RDUS) United States $1.009B 0.00
Aerie Pharmaceuticals (AERI) United States $0.884B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.752B 0.00
Akebia Therapeutics (AKBA) United States $0.722B 0.00
Collegium Pharmaceutical (COLL) United States $0.701B 0.00
Flexion Therapeutics (FLXN) United States $0.697B 0.00
TherapeuticsMD (TXMD) United States $0.640B 0.00
Translate Bio (TBIO) United States $0.600B 0.00
ImmunoGen (IMGN) United States $0.533B 0.00
Ardelyx (ARDX) United States $0.506B 0.00
Organogenesis Holdings (ORGO) United States $0.470B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.470B 57.00
Crinetics Pharmaceuticals (CRNX) United States $0.462B 0.00
Dermira (DERM) United States $0.450B 0.00
Concordia (CXRXF) Canada $0.444B 0.00
Molecular Templates (MTEM) United States $0.441B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.440B 0.00
Harpoon Therapeutics (HARP) United States $0.438B 0.00
DURECT (DRRX) United States $0.423B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.421B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.405B 17.45
Recro Pharma (REPH) United States $0.383B 0.00
Indivior (INVVY) United States $0.379B 1.37
Siga Technologies (SIGA) United States $0.375B 8.57
OptiNose (OPTN) United States $0.374B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.372B 0.00
Lannett Co Inc (LCI) United States $0.357B 4.16
Innate Pharma SA (IPHYF) France $0.339B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.308B 0.00
KalVista Pharmaceuticals (KALV) United States $0.273B 0.00
Rafael Holdings (RFL) United States $0.268B 0.00
GlycoMimetics (GLYC) United States $0.248B 0.00
Calithera Biosciences (CALA) United States $0.241B 0.00
Xeris Pharmaceuticals (XERS) United States $0.238B 0.00
Jounce Therapeutics (JNCE) United States $0.235B 3.14
Matinas Biopharma Holdings (MTNB) United States $0.221B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.221B 0.00
Aquestive Therapeutics (AQST) United States $0.219B 0.00
Ocular Therapeutix (OCUL) United States $0.192B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 32.73
Foamix Pharmaceuticals (FOMX) Israel $0.189B 0.00
Concert Pharmaceuticals (CNCE) United States $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.143B 0.00
IMV INC (IMV) Canada $0.141B 0.00
Redhill Biopharma (RDHL) Israel $0.140B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.137B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.120B 0.00
CannTrust Holdings (CTST) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.106B 0.00
CV Sciences (CVSI) United States $0.104B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.100B 0.00
PolarityTE (PTE) United States $0.084B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.32
Champions Oncology (CSBR) United States $0.076B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.076B 0.00
Aclaris Therapeutics (ACRS) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Capnia (SLNO) United States $0.071B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.060B 0.00
Genocea Biosciences (GNCA) United States $0.060B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
Novan (NOVN) United States $0.056B 0.00
Nivalis Therapeutics (ALPN) United States $0.056B 0.00
CTI BioPharma (CTIC) United States $0.055B 0.00
Natural Alternatives (NAII) United States $0.055B 13.59
Mast Therapeutics (SVRA) United States $0.054B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.052B 0.00
AgeX Therapeutics (AGE) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
IsoRay (ISR) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.036B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.035B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.030B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.025B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.021B 0.00
Shineco (TYHT) China $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
Vical (BBI) United States $0.016B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Lipocine (LPCN) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Forward Pharma (FWP) Denmark $0.000B 0.00